New Enterprise Associates 17, L.P.'s Form 4 filing
NeueHealth, Inc. (NEUE) · filed Oct 6, 2025
- Accession no.
- 0001193125-25-232131
- Filed
- Oct 6, 2025, 5:49 PM ET
- Trade date
- Oct 2, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 5 non-derivative transactions and 5 derivative transactions. Open-market sales total $1.89K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| New Enterprise Associates 17, L.P.CIK 0001768564 | Director, 10% Owner |
| NEA Partners 17, L.P.CIK 0001796820 | Director, 10% Owner |
| Nea 17 GP, LLCCIK 0001796821 | Director, 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 2, 2025 | Common Stock | XIn-the-money exerciseAcquired | +189,195 | $0.01 | +$1,891.95 | 488,982 | Direct | |
| Oct 2, 2025 | Common Stock | SSaleDisposed | −280 | $6.75 | −$1,890 | 488,702 | Direct | |
| Oct 2, 2025 | Common Stock | MOption exerciseAcquired | +186,128 | $0.01 | +$1,861.28 | 674,830 | Direct | |
| Oct 2, 2025 | Common Stock | FTax withholdingDisposed | −276 | $6.75 | −$1,863 | 674,554 | Direct | |
| Oct 2, 2025 | Common Stock | DReturned to the companyDisposed | −674,554 | – | – | 0 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 2, 2025 | Common Stock | XIn-the-money exerciseDisposed | −189,195 | $0.00 | $0 | 0 | Direct | Duplicate filing |
| Oct 2, 2025 | Common Stock | AGrant or awardAcquired | +186,128 | – | – | 186,128 | Direct | |
| Oct 2, 2025 | Common Stock | MOption exerciseDisposed | −186,128 | $0.00 | $0 | 0 | Direct | |
| Oct 2, 2025 | Common Stock | DReturned to the companyDisposed | −330,194 | – | – | 0 | Direct | |
| Oct 2, 2025 | Common Stock | DReturned to the companyDisposed | −509,780 | – | – | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.